Background: The pathophysiologic and clinical relevance of cardiac natriuretic hormone
(CNH) assays has been investigated in numerous experimental and clinical studies. Authors …

Mortality among patients with ESRD remains high because of an excessive cardiovascular
risk related to a very high incidence of cardiac hypertrophy, cardiomyopathy, heart failure …

Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic
Peptide Measurement: Results from the ProBNP Investigation of Dyspnea in the Emergency …

Background: Most patients with chronic kidney disease (CKD) develop cardiovascular
complications. Natriuretic peptides are novel markers that can be used to identify and …

Background: Cardiac failure occasionally is caused by the creation of vascular access for
hemodialysis. However, the influence of an arteriovenous (AV) fistula on cardiac function …

This study was performed to determine whether the N-terminal pro-brain natriuretic peptide
(NT-pro-BNP) is a useful biomarker in predicting cardiovascular congestion, mortality, and …

Background: Brain natriuretic peptide (BNP) is useful for the evaluation of ventricular
dysfunction in patients with various cardiac diseases. However, its diagnostic value has …

BACKGROUND: Although the cardiac biomarker troponin T (cTnT) is related strongly to
mortality in patients with end-stage renal disease, the independent association of N-terminal …

been detected by the MLT, but was more obvious when the patients used this meter. To
evaluate the lot-to-lot variation, we inclu been detected by the MLT, but was more obvious …

BACKGROUND:: Brain natriuretic peptide (BNP) is released into circulation in response to
ventricular dilatation and pressure overload. Plasma BNP concentration correlates with left …